Downregulation of blood monocyte HLA-DR in ICU patients is also present in bone marrow cells

PLoS ONE

Volumn 11, Issue 11, 2016, Pages

  Faivre, Valérie ^a,b   Lukaszewicz, Anne Claire ^a,b,c,d   Payen, Didier ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR2; HLA DR ANTIGEN; L SELECTIN; CCR2 PROTEIN, HUMAN; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITGAM PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD; BONE MARROW CELL; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; MALE; MONOCYTE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SEPSIS; AGED; CASE CONTROL STUDY; INTENSIVE CARE UNIT; METABOLISM; MIDDLE AGED; PATHOLOGY; SEPTIC SHOCK; THROMBOCYTOPENIA;

AGED; ANTIGENS, CD11B; BONE MARROW CELLS; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; GPI-LINKED PROTEINS; HLA-DR ANTIGENS; HUMANS; INTENSIVE CARE UNITS; L-SELECTIN; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; RECEPTORS, CCR2; RECEPTORS, IGG; SHOCK, SEPTIC; THROMBOCYTOPENIA;

EID: 84999018337     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164489     Document Type: Article

References (43)

1. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis. 2013; 13(3):260-8. doi: 10.1016/S1473-3099 (13)70001-X PMID: 23427891
2. Lukaszewicz AC, Faivre V, Payen D. Is monocyte HLA-DR expression monitoring a useful tool to predict the risk of secondary infection? Minerva Anestesiol. 2010; 76(9):737-43. PMID: 20820152
3. Venet F, Foray AP, Villars-Mechin A, Malcus C, Poitevin-Later F, Lepape A, et al. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012; 189(10):5073-81. doi: 10.4049/jimmunol.1202062 PMID: 23053510
4. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011; 306(23):2594-605. doi: 10.1001/jama.2011. 1829 PMID: 22187279
5. Gouel-Cheron A, Allaouchiche B, Guignant C, Davin F, Floccard B, Monneret G, et al. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One. 2012; 7(3):e33095. doi: 10.1371/journal.pone.0033095 PMID: 22431998
6. Lukaszewicz AC, Grienay M, Resche-Rigon M, Pirracchio R, Faivre V, Boval B, et al. Monocytic HLADR expression in intensive care patients: interest for prognosis and secondary infection prediction. Crit Care Med. 2009; 37(10):2746-52. doi: 10.1097/CCM.0b013e3181ab858a PMID: 19707128
7. Cohen J, Opal S, Calandra T. Sepsis studies need new direction. Lancet Infect Dis. 2012; 12(7):503-5. doi: 10.1016/S1473-3099(12)70136-6 PMID: 22742624
8. Landelle C, Lepape A, Voirin N, Tognet E, Venet F, Bohe J, et al. Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive Care Med. 2010; 36(11):1859-66. doi: 10.1007/s00134-010-1962-x PMID: 20652682
9. Venet F, Lukaszewicz AC, Payen D, Hotchkiss R, Monneret G. Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies. Curr Opin Immunol. 2013; 25 (4):477-83. doi: 10.1016/j.coi.2013.05.006 PMID: 23725873
10. Fumeaux T, Pugin J. Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med. 2002; 166(11):1475-82. doi: 10. 1164/rccm.200203-217OC PMID: 12406851
11. Le Tulzo Y, Pangault C, Amiot L, Guilloux V, Tribut O, Arvieux C, et al. Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med. 2004; 169(10):1144-51. doi: 10.1164/rccm.200309-1329OC PMID: 15028560
12. Nance DM, Sanders VM. Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun. 2007; 21(6):736-45. doi: 10.1016/j.bbi.2007.03.008 PMID: 17467231
13. Prendergast AM, Essers MA. Hematopoietic stem cells, infection, and the niche. Ann N Y Acad Sci. 2014; 1310:51-7. doi: 10.1111/nyas.12400 PMID: 24611873
14. Takizawa H, Regoes RR, Boddupalli CS, Bonhoeffer S, Manz MG. Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation. J Exp Med. 2011; 208(2):273-84. doi: 10. 1084/jem.20101643 PMID: 21300914
15. Glatman Zaretsky A, Engiles JB, Hunter CA. Infection-induced changes in hematopoiesis. J Immunol. 2014; 192(1):27-33. doi: 10.4049/jimmunol.1302061 PMID: 24363432
16. Manz MG, Boettcher S. Emergency granulopoiesis. Nat Rev Immunol. 2014; 14(5):302-14. doi: 10. 1038/nri3660 PMID: 24751955
17. Rossi L, Salvestrini V, Ferrari D, Di Virgilio F, Lemoli RM. The sixth sense: hematopoietic stem cells detect danger through purinergic signaling. Blood. 2012; 120(12):2365-75. doi: 10.1182/blood-2012-04-422378 PMID: 22786880
18. Reagan MR, Rosen CJ. Navigating the bone marrow niche: translational insights and cancer-driven dysfunction. Nat Rev Rheumatol. 2016; 12(3):154-68. doi: 10.1038/nrrheum.2015.160 PMID: 26607387
19. Howell K, Posluszny J, He LK, Szilagyi A, Halerz J, Gamelli RL, et al. High MafB expression following burn augments monocyte commitment and inhibits DC differentiation in hemopoietic progenitors. J Leukoc Biol. 2012; 91(1):69-81. doi: 10.1189/jlb.0711338 PMID: 21984745
20. Muthu K, He LK, Melstrom K, Szilagyi A, Gamelli RL, Shankar R. Perturbed bone marrow monocyte development following burn injury and sepsis promote hyporesponsive monocytes. J Burn Care Res. 2008; 29(1):12-21. doi: 10.1097/BCR.0b013e31815fa499 PMID: 18182893
21. Satake S, Hirai H, Hayashi Y, Shime N, Tamura A, Yao H, et al. C/EBPbeta is involved in the amplification of early granulocyte precursors during candidemia-induced "emergency" granulopoiesis. J Immunol. 2012; 189(9):4546-55. doi: 10.4049/jimmunol.1103007 PMID: 23024276
22. Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure [editorial; comment]. Chest. 1992; 101(6)):1481-3. PMID: 1600757
23. van Lochem EG, van der Velden VH, Wind HK, te Marvelde JG, Westerdaal NA, van Dongen JJ. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin Cytom. 2004; 60(1):1-13. doi: 10.1002/cyto.b.20008 PMID: 15221864
24. Brackman D, Lund-Johansen F, Aarskog D. Expression of leukocyte differentiation antigens during the differentiation of HL-60 cells induced by 1,25-dihydroxyvitamin D3: comparison with the maturation of normal monocytic and granulocytic bone marrow cells. J Leukoc Biol. 1995; 58(5):547-55. P PMID: 7595056
25. Auffray C, Sieweke MH, Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol. 2009; 27:669-92. doi: 10.1146/annurev.immunol.021908. 132557 PMID: 19132917
26. Matera G, Puccio R, Giancotti A, Quirino A, Pulicari MC, Zicca E, et al. Impact of interleukin-10, soluble CD25 and interferon-gamma on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study. Crit Care. 2013; 17(2):R64. doi: 10.1186/cc12596 PMID: 23561467
27. Belikova I, Lukaszewicz AC, Faivre V, Damoisel C, Singer M, Payen D. Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med. 2007; 35(12):2702-8. PMID: 18074472
28. Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol. 2006; 169(2):338-46. doi: 10.2353/ajpath.2006.060312 PMID: 16877336
29. Payne KJ, Crooks GM. Immune-cell lineage commitment: translation from mice to humans. Immunity. 2007; 26(6):674-7. doi: 10.1016/j.immuni.2007.05.011 PMID: 17582340
30. Lund-Johansen F, Terstappen LW. Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol. 1993; 54(1):47-55. PMID: 7687642
31. Arnoulet C, Bene MC, Durrieu F, Feuillard J, Fossat C, Husson B, et al. Four-and five-color flow cytometry analysis of leukocyte differentiation pathways in normal bone marrow: a reference document based on a systematic approach by the GTLLF and GEIL. Cytometry B Clin Cytom. 2010; 78(1):4-10. doi: 10. 1002/cyto.b.20484 PMID: 19708072
32. Bender JG, Unverzagt KL, Walker DE, Lee W, Van Epps DE, Smith DH, et al. Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood. 1991; 77(12):2591-6. PMID: 1710512
33. Harrington A, Olteanu H, Kroft S. The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders. Am J Clin Pathol. 2010; 134(5):749-61. doi: 10.1309/AJCPFNF5MN1GDWKU PMID: 20959658
34. Kussick SJ, Wood BL. Using 4-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med. 2003; 127(9):1140-7. PMID: 12946231
35. Xu Y, McKenna RW, Karandikar NJ, Pildain AJ, Kroft SH. Flow cytometric analysis of monocytes as a tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. Am J Clin Pathol. 2005; 124(5):799-806. doi: 10.1309/HRJ1-XKTD-77J1-UTFM PMID: 16203279
36. Serbina NV, Jia T, Hohl TM, Pamer EG. Monocyte-mediated defense against microbial pathogens. Annu Rev Immunol. 2008; 26:421-52. doi: 10.1146/annurev.immunol.26.021607.090326 PMID: 18303997
37. Abeles RD, McPhail MJ, Sowter D, Antoniades CG, Vergis N, Vijay GK, et al. CD14, CD16 and HLADR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLADR expression by CD14(hi)/CD16(neg) monocytes: Expansion of CD14(hi)/CD16(pos) and contraction of CD14(lo)/CD16(pos) monocytes in acute liver failure. Cytometry A. 2012; 81(10):823-34. doi: 10.1002/cyto.a.22104 PMID: 22837127
38. Nguyen HH, Tran BT, Muller W, Jack RS. IL-10 acts as a developmental switch guiding monocyte differentiation to macrophages during a murine peritoneal infection. J Immunol. 2012; 189(6):3112-20. doi: 10.4049/jimmunol.1200360 PMID: 22869902
39. Elghetany MT, Ge Y, Patel J, Martinez J, Uhrova H. Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: correlation with morphologic assessments. J Clin Lab Anal. 2004; 18(1):36-41. doi: 10.1002/jcla.20001 PMID: 14730556
40. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med. 1997; 3(6):678-81. PMID: 9176497
41. Kamp VM, Leentjens J, Pillay J, Langereis JD, de Kleijn S, Kox M, et al. Modulation of granulocyte kinetics by GM-CSF/IFN-gamma in a human LPS rechallenge model. J Leukoc Biol. 2013; 94(3):513-20. doi: 10.1189/jlb.0213066 PMID: 23794709
42. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med. 2009; 180(7):640-8. doi: 10.1164/rccm.200903-0363OC PMID: 19590022
43. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol. 2013; 13(12):862-74. doi: 10.1038/nri3552 PMID: 24232462